LungBiomarker

Block number:
Tumor content:

Molecular:

EGFR:
    No mutation detected
    Mutation identified:
    Cannot be determined:

ALK:
    No rearrangement detected
    Rearrangement identified:
    Cannot be determined:

ROS1:
    No rearrangement detected
    Rearrangement identified:
    Cannot be determined:

RET:
    No rearrangement detected
    Rearrangement identified:
    Cannot be determined:

KRAS:
    No mutation detected
    Mutation identified:
    Cannot be determined:

BRAF:
    No mutation detected
    Mutation identified:
    Cannot be determined:

ERBB2:
    No mutation detected
    Mutation identified:
    Cannot be determined:

MET Mutational Analysis:
    No mutation detected
    Mutation identified:
    Cannot be determined:

MET Copy Number Analysis:
    No amplification detected
    Amplification identified: Copies: Ratio:
    Cannot be determined:

Other Gene :
    No mutation detected
    Mutation identified:
    Cannot be determined:

Immunohistochemistry:

EGFR L858R (clone 43B2):
    Negative
    Positive
    Equivocal:

EGFR exon 19 deletion (E746_A750del) (clone 6B6):
    Negative
    Positive
    Equivocal:

ALK (D5F3):
    Negative
    Positive
    Equivocal:

ROS1:
    Negative
    Positive
    Equivocal:

BRAF V600E:
    Negative
    Positive
    Equivocal:

PD-L1 22C3 FDA (Keytruda):
       Interpretation:
        No expression
        Expressed
        High expression
       Tumor Proportion Score: %
       Intensity:
        Absent
        1+
        2+
        3+

Other Stain :
    Negative
    Positive
    Equivocal:

Methodology:
Can paste here:

EGFR:
Exons assessed:
ALK:
ROS1:
RET:
KRAS:
Codons assessed:
BRAF:
Exons assessed:
ERBB2:
Exons assessed:
MET Mutations:
Regions assessed:
MET Copy Number: